Evaluating Atorvastatin With Omega-3 Fatty Acids in Cardiovascular Risk Reduction in Patients With Type 2 Diabetes
Clinical trial NCT00141232 · COMPLETED
Trial details
- NCT number
- NCT00141232
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-11-01
- Enrollment
- 810
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.